| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 20.114 | 6.375 | 5.097 | 0 | 0 |
| Total Income - EUR | - | - | - | - | - | 20.114 | 6.375 | 5.097 | 0 | 0 |
| Total Expenses - EUR | - | - | - | - | - | 14.830 | 1.157 | 2.618 | 0 | 0 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 5.284 | 5.217 | 2.480 | 0 | 0 |
| Net Profit/Loss - EUR | - | - | - | - | - | 4.756 | 5.030 | 2.405 | 0 | 0 |
| Employees | - | - | - | - | - | 0 | 1 | 0 | 0 | 0 |
Check the financial reports for the company - Premium Biocompany Cvg S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | - | - | 6.989 | 12.907 | 15.352 | 15.305 | 15.220 |
| Inventories | - | - | - | - | - | 3.332 | 3.194 | 3.203 | 3.194 | 3.176 |
| Receivables | - | - | - | - | - | 271 | 5.957 | 8.455 | 8.430 | 8.382 |
| Cash | - | - | - | - | - | 3.385 | 3.756 | 3.693 | 3.682 | 3.661 |
| Shareholders Funds | - | - | - | - | - | 4.798 | 9.721 | 12.156 | 12.119 | 12.052 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 2.191 | 3.185 | 3.195 | 3.186 | 3.168 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "2042 - 2042" | |||||||||
| CAEN Financial Year |
2042
|
|||||||||
Comments - Premium Biocompany Cvg S.r.l.